Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Chronic Eosinophilic Leukemia
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Leukemia (2149
)
Acute Myelogenous Leukemia (1007
)
Acute Lymphocytic Leukemia (417
)
Chronic Lymphocytic Leukemia (326
)
Chronic Myeloid Leukemia (267
)
B Acute Lymphoblastic Leukemia (193
)
T Acute Lymphoblastic Leukemia (39
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (23
)
Chronic Myelomonocytic Leukemia (20
)
Prolymphocytic Leukemia (17
)
Acute Promyelocytic Leukemia (12
)
Juvenile Myelomonocytic Leukemia (5
)
Chronic Neutrophilic Leukemia (3
)
Leukemia (2149
)
Acute Myelogenous Leukemia (1007
)
Acute Lymphocytic Leukemia (417
)
Chronic Lymphocytic Leukemia (326
)
Chronic Myeloid Leukemia (267
)
B Acute Lymphoblastic Leukemia (193
)
T Acute Lymphoblastic Leukemia (39
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (23
)
Chronic Myelomonocytic Leukemia (20
)
Prolymphocytic Leukemia (17
)
Acute Promyelocytic Leukemia (12
)
Juvenile Myelomonocytic Leukemia (5
)
Chronic Neutrophilic Leukemia (3
)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
KIT M541L
Chronic Eosinophilic Leukemia
KIT M541L
Chronic Eosinophilic Leukemia
imatinib
Sensitive: C3 – Early Trials
imatinib
Sensitive
:
C3
imatinib
Sensitive: C3 – Early Trials
imatinib
Sensitive
:
C3
PCM1-JAK2 fusion
Chronic Eosinophilic Leukemia
PCM1-JAK2 fusion
Chronic Eosinophilic Leukemia
ruxolitinib
Sensitive: C3 – Early Trials
ruxolitinib
Sensitive
:
C3
ruxolitinib
Sensitive: C3 – Early Trials
ruxolitinib
Sensitive
:
C3
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
YD312
Sensitive: C4 – Case Studies
YD312
Sensitive
:
C4
YD312
Sensitive: C4 – Case Studies
YD312
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login